1. Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials
   Donna M. Peehl et al, 2023, Tomography CrossRef
2. SLC11A1 as a stratification indicator for immunotherapy or chemotherapy in patients with glioma
   Houshi Xu et al, 2022, Frontiers in Immunology CrossRef
3. Patient-Derived Organoids: The Beginning of a New Era in Ovarian Cancer Disease Modeling and Drug Sensitivity Testing
   Iason Psilopatis et al, 2022, Biomedicines CrossRef
4. Overview of the progress and prospects of SMAC mimetics in cancers: Is it a silver bullet?
   Elvina Almuradova et al, 2022, Arhiv za farmaciju CrossRef
5. Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck
   Robert L. Ferris et al, 2023, Cancer Treatment Reviews CrossRef
6. Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
   Yan-Ruide Li et al, 2023, iScience CrossRef
7. DFT study of carboplatin encapsulation interactions with carboxylated carbon nanotubes and conjugated to folic acid for targeted nano delivery systems
   Umme Hani et al, 2023, Alexandria Engineering Journal CrossRef
8. Metabolomics profiling and chemoresistance mechanisms in ovarian cancer cell lines: Implications for targeting glutathione pathway
   Pedro Alarcon-Zapata et al, 2023, Life Sciences CrossRef
9. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
   Vanja Tadić et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis
    Courtney E. McAleese et al, 2022, Breast Cancer Research and Treatment CrossRef